Close
  Indian J Med Microbiol
 

Figure 5: Results of TAC assay in single and combined treated cases with EGCG and CP after 24 h in esophageal cancer cells. Data are presented as mean ± SD. ***P < 0.001 indicates significant differences compared to the untreated control, ###P < 0.001versus EGCG (IC50), and $$$P < 0.001 against CP (IC50) group. CP, Carboplatin; EGCG, epigallocatechin-3-gallate; TAC, total antioxidant capacity

Figure 5: Results of TAC assay in single and combined treated cases with EGCG and CP after 24 h in esophageal cancer cells. Data are presented as mean ± SD. ***<i>P</i> < 0.001 indicates significant differences compared to the untreated control, <sup>###</sup><i>P</i> < 0.001versus EGCG (IC<sub>50</sub>), and <sup>$$$</sup><i>P</i> < 0.001 against CP (IC<sub>50</sub>) group. CP, Carboplatin; EGCG, epigallocatechin-3-gallate; TAC, total antioxidant capacity